Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acumen Pharmaceuticals Inc
(NQ:
ABOS
)
2.640
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acumen Pharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
Gainers
Via
Benzinga
Acumen Pharma's Stock Doubles In One Session - Here's Why
July 17, 2023
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) presented topline results from the Phase 1 INTERCEPT-AD trial of ACU193, the first clinical-stage amyloid beta oligomers (AβO) targeting antibody therapy in...
Via
Benzinga
Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?
July 17, 2023
BYND Cannasoft Enterprise (BCAN) stock is dropping on Monday after the company announced an underwritten stock offering.
Via
InvestorPlace
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?
July 17, 2023
Quoin Pharmaceuticals (QNRX) stock is taking a massive beating on Monday as the company prepares for an ADS ratio change.
Via
InvestorPlace
Why Is Argenx (ARGX) Stock Up 27% Today?
July 17, 2023
Argenx (ARGX) stock is climbing higher on Monday following the release of data from a Phase 1 clinical trial of VYVGART Hytrulo.
Via
InvestorPlace
Earnings Outlook For Acumen Pharmaceuticals
May 08, 2023
Via
Benzinga
Earnings Preview For Acumen Pharmaceuticals
March 24, 2023
Via
Benzinga
Why Is Acumen Pharmaceuticals (ABOS) Stock Up 46% Today?
July 17, 2023
Acumen Pharmaceuticals (ABOS) stock is on the rise Monday after the company released data from a Phase 1 clinical trial.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Acumen Pharmaceuticals to Hold Conference Call to Discuss Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease
July 17, 2023
Company to host conference call and webcast for investors and analysts today, July 17, at 8 a.m. ET
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
July 16, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 11, 2023
Via
Benzinga
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 11, 2023
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
Acumen Pharmaceuticals to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease During Featured Research Session at the Alzheimer’s Association International Conference (AAIC®) 2023
June 13, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
May 18, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
May 09, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Something Happened In Biotech Last Week
May 08, 2023
Biotech stocks were more constructive last week with some sharp moves up.
Via
Talk Markets
Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference
May 04, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023
May 02, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Acumen Pharmaceuticals Presents in vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimer’s Disease
March 28, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
5 Value Stocks In The Healthcare Sector
March 27, 2023
Via
Benzinga
Earnings Scheduled For March 27, 2023
March 27, 2023
Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...
Via
Benzinga
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights
March 27, 2023
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.